Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion.

MLA

Maeda, Noboru, et al. “Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion.” CardioVascular & Interventional Radiology, vol. 35, no. 1, Feb. 2012, pp. 82–89. EBSCOhost, https://doi.org/10.1007/s00270-010-0086-6.

APA

Maeda, N., Osuga, K., Higashihara, H., Tomoda, K., Mikami, K., Nakazawa, T., Nakamura, H., & Tomiyama, N. (2012). Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion. CardioVascular & Interventional Radiology, 35(1), 82–89. https://doi.org/10.1007/s00270-010-0086-6

Chicago

Maeda, Noboru, Keigo Osuga, Hiroki Higashihara, Kaname Tomoda, Koji Mikami, Tetsuro Nakazawa, Hironobu Nakamura, and Noriyuki Tomiyama. 2012. “Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion.” CardioVascular & Interventional Radiology 35 (1): 82–89. doi:10.1007/s00270-010-0086-6.